Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction

PHASE4CompletedINTERVENTIONAL
Enrollment

2,404

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

July 5, 2021

Study Completion Date

July 5, 2021

Conditions
Healthy
Interventions
BIOLOGICAL

Meningococcal B

Bexsero is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B.

BIOLOGICAL

High-Dose TIV

Fluzone High-Dose is an injectable influenza vaccine made to protect against the flu strains most likely to cause illness for that particular flu season.

BIOLOGICAL

Tdap (tetanus-diphtheria-acellular pertussis)

Tdap is a combination vaccine that protects against three potentially life-threatening bacterial diseases: tetanus, diphtheria, and pertussis (whooping cough).

BIOLOGICAL

Meningococcal ACWY

Meningococcal ACWY vaccine is indicated for active immunization of individuals up to 55 years of age against invasive meningococcal diseases caused by Neisseria meningitides serogroups A, C, W-135 and Y.

BIOLOGICAL

Herpes Zoster

Herpes zoster vaccine is indicated for the immunization of individuals 50 years of age or older for the prevention of herpes zoster (shingles).

BIOLOGICAL

Travel Health (Hepatitis A, Hepatitis B, Typhoid Fever)

Hepatitis A vaccine is indicated for immunization against infections caused by hepatitis A virus; Hepatitis B vaccine is indicated for immunization against infection caused by hepatitis B virus; and typhoid fever vaccine is indicated for active immunization against Salmonella typhi, the organism which causes typhoid fever.

Trial Locations (1)

B3K 6R8

IWK Health Centre, Halifax

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

MCM Vaccines B.V.

INDUSTRY

collaborator

Canadian Center for Vaccinology

OTHER

collaborator

Dalhousie University

OTHER

lead

Canadian Immunization Research Network

NETWORK

NCT02868970 - Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction | Biotech Hunter | Biotech Hunter